AcuraStem
AcuraStem harnesses human, patient-specific in vitro cell models and assays to develop cures and improve diagnoses in disorders of the CNS.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed AcuraStem Information
Geographic Data
Address: 605 E. Huntington Dr
City: Monrovia
State: CA
Zip: 91016-6352
Country: US
Financial Info
Stage:
grant
Raised Last:
$1M
Raised Total:$1M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
AcuraStem is a startup company that was formed in 2016 to create an innovative precision medicine platform. They are a team of PhDs, professors, tech entrepreneurs, and successful drug company veterans employing the latest scientific breakthroughs to address one of the most challenging, but they believe tractable, health problems of their time —Amyotrophic Lateral Sclerosis (ALS). AcuraStem harnesses advanced cellular reprogramming and artificial intelligence technologies to transform the standard of care for neurodegenerative diseases through patient-specific treatment.
Contact Phone:
+12132900635
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2019 | Convertible Note | 2 | $1M |
Keiretsu Forum Viva Biotech Keiretsu Forum Viva Biotech |
10/2019 | Grant | 1 | $3M |
Small Business Innovation Research Small Business Innovation Research |
5/2021 | Grant | 1 | $1M |
Congressionally Directed Medical Research Programs Congressionally Directed Medical Research Programs |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
